Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Position Reduced by YHB Investment Advisors Inc.

YHB Investment Advisors Inc. cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% during the third quarter, HoldingsChannel.com reports. The firm owned 21,996 shares of the medical equipment provider’s stock after selling 763 shares during the period. Intuitive Surgical makes up about 0.9% of YHB Investment Advisors Inc.’s portfolio, making the stock its 26th largest holding. YHB Investment Advisors Inc.’s holdings in Intuitive Surgical were worth $10,806,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Creekmur Asset Management LLC grew its position in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares in the last quarter. Ridgewood Investments LLC bought a new stake in Intuitive Surgical in the second quarter worth approximately $26,000. Delos Wealth Advisors LLC grew its position in Intuitive Surgical by 380.0% in the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares in the last quarter. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. Finally, LRI Investments LLC acquired a new stake in shares of Intuitive Surgical in the first quarter worth $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ISRG has been the subject of a number of analyst reports. Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners boosted their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Morgan Stanley upped their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Finally, BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $513.74.

Insider Buying and Selling

In related news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Amy L. Ladd sold 450 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the sale, the director now directly owns 821 shares of the company’s stock, valued at approximately $402,519.88. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 51,455 shares of company stock valued at $24,911,155. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Down 1.0 %

Intuitive Surgical stock opened at $512.58 on Thursday. The company has a market cap of $181.81 billion, a PE ratio of 92.52, a PEG ratio of 5.40 and a beta of 1.39. The company’s 50-day moving average is $486.71 and its two-hundred day moving average is $440.96. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $523.34.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.